Botox and Blepharospasm

Blepharospasm is a medical condition that refers to an uncontrollable blinking of the eyelid. Sufferers have great difficulty performing simple tasks such as walking, since the continuous blinking makes it hard to see the path on which they move. It generally affects both eyes, although only one eye may be affected when the condition is just beginning to take root.

The preferred treatment for blepharospasm is Botox. A single injection produces results that last for a few months, therefore treatments must be repeated. However, most sufferers prefer getting Botox to other treatments such as surgery and medication, since it involves a noninvasive procedure that achieves fast and effective results.

New Labeling

Health Canada has forced Allergan to put a new warning label on one of its most popular cosmetic products, Botox. The new label will include a warning about distant toxin spread that could have potentially fatal consequences.

However, some physicians believe that the toxin in Botox rarely spreads when injected for the elimination of wrinkles since only very low doses are administered. Distant toxin spread may only result when the product is used for medical purposes, in the treatment of spasticity or serious neurological ailments, as higher amounts are generally needed. It is also believed that off-label uses or physicians who are inexperienced and lack adequate training can increase the risk of distant toxin spread occurring.

For cosmetic purposes, Botox has been approved to treat frown lines, glabellar lines, and crows’ feet.